Brief: MedMira Says New EUA Application To Be Submitted To U.S. FDA In 10 Business Days For Revealcovid-19 Plus Total Antibody Test

MedMira

31/12/2020 02:14

Dec 30 (Reuters) - MedMira Inc  MIR.V :
    * ANNOUNCES ITS VALIDATED REVEALCOVID-19 PLUS TOTAL ANTIBODY
TEST
FOR DETECTION OF TOTAL ANTIBODIES AGAINST SARS-COV-2
    * REVEALCOVID-19(TM) PLUS TOTAL ANTIBODY TEST IS AN UPDATE
TO
MEDMIRA'S REVEALCOVID-19(TM) TOTAL ANTIBODY TEST
    * A NEW EUA APPLICATION WILL BE SUBMITTED TO U.S. FDA WITHIN
10
BUSINESS DAYS
    * CO WILL SUBMIT NEW INTERIM ORDER APPLICATION TO SEEK
HEALTH
CANADA AUTHORIZATION OF REVEALCOVID-19(TM) PLUS TOTAL ANTIBODY
TEST

Source text for Eikon:  ID:nGNX4lJ4Vd 
Further company coverage:  MIR.V 

 ((Reuters.Briefs@thomsonreuters.com;))